← All Sponsors
SPONSOR

Protara Therapeutics

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Lymphatic Malformation
NCT05871970 Phase 2
Recruiting

Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age

Lymphatic Malformation
United States View Trial →